In Person
Tuesday, October 6, 2026 at 5:15 PM CDT
Le Méridien St. Louis Clayton
7730 Bonhomme Avenue, Clayton, St. Louis, MO, USA
Join oncology professionals from across Missouri for an engaging evening of dinner, networking, and connection at the highly anticipated MOS 2026 Fall Conference in St. Louis, bringing together members of the oncology community along with industry partners for an evening of meaningful conversation and collaboration.
View Agenda & Provider RegistrationYour professional development is important to us! Please check back for upcoming event listings about upcoming meetings and educational opportunities.
If you are employed by a pharmaceutical/device manufacturer, consulting, or technology company, please contact corporaterelations@oss-oncology.org.
MOS is proud to partner with organizations that share the mission of educating the oncology community. The events listed below are listed for your information, and any questions about the events below should be directed towards the organizers.
September 17th-18th, 2026
Location: Marriott St. Louis Grand Hotel
Presented by Horizon CME
The APP Oncology Summit is a two-day conferencedesigned to provide advanced practice providers (APPs) with the latest evidence-based strategies to optimize care and outcomes for patients with cancer. This conference is planned with and for advanced practice providers (NPs, PAs, pharmacists, and nurse specialists) and is a collaborative effort of oncology clinicians from multiple organizations in each community. The APP Oncology Summit offers a unique opportunity for APPs from various healthcare teams in the community to collaborate, learn from each other and national faculty, and share best practices on a range of issues related to the care of cancer patients.
September 23, 2026
Location: Hyatt Regency St. Louis at The Arch
You're invited to participate in the Targeted Oncology Community Case Forum on September 23 at the Hyatt Regency St. Louis at The Arch.
Targeted Oncology events are held in partnership with Healthcare Research & Analytics (HRA®) to gain market research insights into health care professionals' educational needs in their current practice setting. With prior approval from our registration team, a small number of fellows and advanced practice providers may be eligible to attend. HRA offers compensation for consultative contributions during the event discussions, responses to polling questions, and completion of a postevent survey.
At the CCF, attendees will have the chance to network with other local oncologists before participating in 1 of 2 case-based discussions: Clinical Considerations and Therapeutic Sequencing of BTK Inhibitors in R/R CLL or Targeted Treatment of Radioiodine-Refractory, Differentiated Thyroid Cancers. Don't delay; seating is limited for each moderated discussion.